Cholestasis progression effects on long-term memory in bile duct ligation rats

Hosseini, Nasrin; Kashefi, Parviz; Alaei, Hojjatallah; Zarrindast, Mohammad Reza; Honarmand, Azim; Nasehi, Mohammad; Radahmadi, Maryam

Cholestasis progression effects on long-term memory in bile duct ligation rats

Authors

¹ Department of Cognitive Neuroscience, Institute for Cognitive Science Studies, Tehran, Iran

² Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

³ Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

⁴ Department of Cognitive Neuroscience, Institute for Cognitive Science Studies; Department of Neuroscience, School of Advanced Medical Technologies and Department of Pharmacology, School of Medicine; Department of Addiction Studies, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran

⁵ Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Garmsar Branch, Garmsar, Iran

Abstract

Background : There is evidence that cognitive functions are affected by some liver diseases such as cholestasis. Bile duct ligation induces cholestasis as a result of impaired liver function and cognition. This research investigates the effect of cholestasis progression on memory function in bile duct ligation rats.
Materials and Methods: Male Wistar rats were randomly divided into five groups, which include: control group for BDL-7, control group for BDL-21, sham group (underwent laparotomy without bile duct ligation), BDL-7 group (7 days after bile duct ligation), and BDL-21 group (21 days after bile duct ligation). Step-through passive avoidance test was employed to examine memory function. In all groups, short-term (7 days after foot shock) and long-term memories (21 days after foot shock) were assessed.
Results: Our results showed that liver function significantly decreased with cholestasis progression (P < 0.01). Also our findings indicated BDL-21 significantly impaired acquisition time (P < 0.05). Memory retrieval impaired 7 (P < 0.05) and 21 days (P < 0.001) after foot shock in BDL-7 and BDL-21 groups, respectively.
Conclusion: Based on these findings, liver function altered in cholestasis and memory (short-term and long-term memory) impaired with cholestasis progression in bile duct ligation rats. Further studies are needed to better insight the nature of progression of brain damage in cholestatic disease.

Keywords

References

1.	Roma M, Crocenzi F. Hepatocellular transport in acquired cholestasis: New insights into functional, regulatory and therapeutic aspects. Clin Sci 2008;114:567-88.
2.	Sheen JM, Huang LT, Hsieh CS, Chen CC, Wang JY, Tain YL. Bile duct ligation in developing rats: Temporal progression of liver, kidney, and brain damage. J Pediatr Surg 2010;45:1650-8.
3.	Aksu B, Umit H, Kanter M, Guzel A, Aktas C, Civelek S, et al. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats. Acta Histochem 2010;112:259-69.
4.	Huang LT, Chen CC, Sheen JM, Chen YJ, Hsieh CS, Tain YL. The interaction between high ammonia diet and bile duct ligation in developing rats: Assessment by spatial memory and asymmetric dimethylarginine. Int J Dev Neurosci 2010;28:169-74.
5.	Garcia-Ayllon M, Silveyra MX, Candela A, Compan A, Claria J, Jover R, et al. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation. Hepatology 2006;43:444-53.
6.	Zarrindast MR, Hoseindoost S, Nasehi M. Possible interaction between opioidergic and cholinergic systems of CA1 in cholestasis-induced amnesia in mice. Behav Brain Res 2012;228:116-24.
7.	Hajrasouliha AR, Tavakoli S, Jabehdar-Maralani P, Ebrahimi F, Shafaroodi H, Mirkhani SH, et al. Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: The role of endogenous opioid peptides. J Hepatol 2005;43:491-8.
8.	Leung N, Croatt AJ, Haggard JJ, Grande JP, Nath KA. Acute cholestatic liver disease protects against glycerol-induced acute renal failure in the rat. Kidney Int 2001;60:1047-57.
9.	Swain MG. Cytokines and neuroendocrine dysregulation in obstructive cholestasis: Pathophysiological implications. J Hepatol 2001;35:416-8.
10.	Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation. J Hepatol 2009;51:528-34.
11.	Monfort P, Muñoz MD, ElAyadi A, Kosenko E, Felipo V. Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis 2002;17:237-50.
12.	Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-9.
13.	Huang LT, Tiao MM, Tain YL, Chen CC, Hsieh CS. Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr Res 2009;65:176-80.
14.	Ryan C, Than T, Blumgart L. Choledochoduodenostomy in the rat with obstructive jaundice. J Surg Res 1977;23:321-31.
15.	Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier Jr RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-21.
16.	Morris R, Garrud P, Rawlins J, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-3.
17.	Hosseini N, Nasehi M, Radahmadi M, Zarrindast MR. Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats. Behav Brain Res 2013;256:636-45.
18.	Garcia-Moreno L, Conejo N, González-Pardo H, Aller M, Nava M, Arias J, et al. Evaluation of two experimental models of hepatic encephalopathy in rats. Braz J Med Biol Res 2005;38:127-32.
19.	Cahill L, Weinberger NM, Roozendaal B, McGaugh JL. Is the amygdala a locus of "conditioned fear"? Some questions and caveats. Neuron 1999;23:227-8.
20.	Rastegar H, Homayoun H, Afifi M, Rezayat M, Dehpour AR. Modulation of cholestasis-induced antinociception by CCK receptor agonists and antagonists. Eur Neuropsychopharmacol 2002;12:111-8.
21.	Nasehi M, Sahebgharani M, Haeri-Rohani A, Zarrindast MR. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol Learn Mem 2009;92:391-9.
22.	Gartung C, Ananthanarayanan M, Rahman M, Schuele S, Nundy S, Soroka C, et al. Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology 1996;110:199-209.
23.	Woodman D, Maile P. Bile acid assays as an index of cholestasis. Clin Chem 1981;27:846-8.
24.	Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility-molecular mechanisms. Clin Liver Dis 2008;12:915-37.
25.	Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305-11.
26.	Michalak A, Knecht K, Butterworth RF. Hepatic encephalopathy in acute liver failure: Role of the glutamate system. Adv Exp Med Biol 1997;420:35-43.
27.	Tarter RE, Arria AM, Carra J, Van Thiel DH. Memory impairments concomitant with nonalcoholic cirrhosis. Int J Neurosci 1987;32:853-9.
28.	Nasehi M, Tackallou SH, Hasani I, Nasehi M. Cholestasis impaired spatial and non-spatial novelty detection in mice. Neurobiol Learn Mem 2013;4:2008-4978.
29.	Aronson DC, Chamuleau RA, Frederiks WM, Gooszen HG, Heijmans HS, James J. Reversibility of cholestatic changes following experimental common bile duct obstruction: Fact or fantasy? J Hepatol 1993;18:85-95.
30.	Javadi-Paydar M, Ghiassy B, Ebadian S, Rahimi N, Norouzi A, Dehpour AR. Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats. Behav Pharmacol 2013;24:195-206.
31.	Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM, et al. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 2004;40:742-8.
32.	Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003;39:320-5.
33.	Jover R, Rodrigo R, Felipo V, Insausti R, Saez-Valero J, García-Ayllón M, et al. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis. Hepatology 2006;43:1257-66.
34.	Cauli O, López-Larrubia P, Rodrigues TB, Cerdán S, Felipo V. Magnetic resonance analysis of the effects of acute ammonia intoxication on rat brain. Role of NMDA receptors. J Neurochem 2007;103:1334-43.
35.	Pantiga C, Rodrigo LR, Cuesta M, Lopez L, Arias JL. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatry Clin Neurosci 2003;15:84-9.
36.	Nasehi M, Piri M, Abbolhasani K, Zarrindast MR. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice. Behav Pharmacol 2013;24:180-94.
37.	Stewart SM, Campbell RA, McCallon D, Waller DA, Andrews WS. Cognitive patterns in school-age children with end-stage liver disease. J Dev Behav Pediatr 1992;13:331-8.
38.	Keller JN, Guo Q, Holtsberg F, Bruce-Keller A, Mattson MP. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J Neurosci 1998;18:4439-50.
39.	Keller JN, Mattson MP. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998;9:105-16.
40.	Swain MG, Maric M. Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. Hepatology 1997;25:291-4.
41.	Soares DD, Coimbra CC, Marubayashi U. Tryptophan-induced central fatigue in exercising rats is related to serotonin content in preoptic area. Neurosci Lett 2007;415:274-8.
42.	Celik T, Goren MZ, Cýnar K, Gurdal H, Onder FO, Tan A, et al . Fatigue of cholestasis and the serotoninergic neurotransmitter system in the rat. Hepatology. 2005;41:731-7.
43.	Burak KW, Le T, Swain MG. Increased midbrain 5-HT- 1A receptor number and responsiveness in cholestatic rats. Brain Res 2001;892:376-9.
44.	Bearn J, Wessely S. Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest 1994;24:79-90.
45.	Thornton J, Losowsky M. Opioid peptides and primary biliary cirrhosis. BMJ 1988;297:1501-4.
46.	Bergasa NV, Jones EA. The pruritus of cholestasis: Potential pathogenic and therapeutic implications of opioids. Gastroenterology 1995;108:1582-8.
47.	Terzioglu B, Aypak C, Yananlý HR, Kucukibrahimoglu E, Yurdaydýn C, Goren MZ. 5-hydroxytryptamine release in the anterior hypothalamic and the hippocampal areas of cholestatic rats. Life Sci 2006;78:1078-83.
48.	Zietz B, Wengler I, Messmann H, Lock G, Schölmerich J, Straub RH. Early shifts of adrenal steroid synthesis before and after relief of short-term cholestasis. J Hepatol 2001;35:329-37.

Advanced Biomedical Research